Apr 15, 2025 8:00am EDT Ensysce Biosciences Announces Positive Data from Opioid Overdose Protection Study
Mar 31, 2025 8:00am EDT Ensysce Biosciences, Inc. Announces $1.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules